Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants

J J Schnorr1, F T Cutts, J G Wheeler

  • 1Institute for Virology and Immunobiology of the University of Würzburg, Versbacher Strasse 7, D-97078, Würzburg, Germany. jjschnorr@med.uni.tuebingen.de

Vaccine
|February 13, 2001
PubMed

Insights

Measles vaccination in infants aged 9 months, or two doses at 6 and 9 months, showed high seroconversion rates. Both schedules induced prolonged immune activation and reduced hypersensitivity responses in young children.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Measles vaccination is critical for child survival, but concerns exist regarding early administration's impact on infant immunity.
  • Previous studies indicated increased mortality with high-titer measles vaccines given before 7 months, prompting investigation into standard-titer vaccine effects.

Purpose of the Study:

  • To evaluate the immunological response to standard-titer measles vaccines in Bangladeshi infants.
  • To compare immune responses between a single vaccine dose at 9 months versus two doses at 6 and 9 months of age.

Main Methods:

  • Assessed seroconversion rates and delayed-type hypersensitivity (DTH) reactions to Candida antigen.
  • Analyzed peripheral blood lymphocyte activation markers and Interleukin-2 (IL-2) production post-vaccination.
  • Compared immune responses between vaccine groups and unvaccinated controls.

Main Results:

  • Vaccination at 9 months achieved 95% seroconversion; two doses at 6 and 9 months resulted in 70% seroconversion.
  • Both vaccination schedules significantly reduced DTH responses at 6 weeks post-vaccination.
  • Sustained increases in lymphocyte activation markers and IL-2 production were observed up to 24 weeks post-vaccination in both groups.

Conclusions:

  • Standard-titer measles vaccination in infants induces prolonged immune activation and transiently suppresses DTH responses.
  • The findings highlight complex immunological effects of measles vaccination in young infants, warranting further clinical investigation.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...